Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago

BACKGROUND/AIM: New direct-acting antivirals (DAAs) provide an opportunity to combat hepatitis C virus (HCV) infection in persons who inject drugs (PWID). Here we use a mathematical model to predict the impact of a DAA-treatment scale-up on HCV prevalence among PWID and the estimated cost in metropo...

Descripción completa

Detalles Bibliográficos
Autores principales: Echevarria, Desarae, Gutfraind, Alexander, Boodram, Basmattee, Major, Marian, Del Valle, Sara, Cotler, Scott J, Dahari, Harel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546683/
https://www.ncbi.nlm.nih.gov/pubmed/26295805
http://dx.doi.org/10.1371/journal.pone.0135901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546683/
https://www.ncbi.nlm.nih.gov/pubmed/26295805
http://dx.doi.org/10.1371/journal.pone.0135901

Ejemplares similares